Recent News for CLSN - Celsion Corporation

Date Title
Apr 7 Celsion Corporation closes stock offering
Apr 5 CELSION CORPORATION ANNOUNCES CLOSING OF $15 MILLION REGISTERED DIRECT OFFERING
Apr 1 Celsion's Ovarian Cancer Immunotherapy Shows 41% Improvement In R0 Resection Rates
Apr 1 Poster on Celsion Corporation’s Phase I/II OVATION 2 Study Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer
Mar 31 Why VTSI Stock AND CLSN Stock Are Trading Lower Today
Mar 31 Celsion stock plunges 14% on proposing $15M registered direct offering
Mar 31 CELSION CORPORATION ANNOUNCES $15 MILLION REGISTERED DIRECT OFFERING
Mar 19 Celsion Corporation (CLSN) CEO Michael Tardugno on Q4 2020 Results - Earnings Call Transcript
Mar 19 Celsion shares fall 8% despite earnings beat
Mar 19 Celsion EPS beats by $0.06, revenue in-line
Mar 19 Celsion Corporation Reports 2020 Financial Results and Provides Business Update
Mar 19 Earnings Scheduled For March 19, 2021
Mar 12 Celsion Corporation to Hold Year-End 2020 Financial Results and Business Update Conference Call on Friday, March 19, 2021
Mar 5 NeoPhotonics to Host Call to Discuss Optical Communications Trends and Technologies on March 10, 2021
Mar 5 Do Options Traders Know Something About Celsion (CLSN) Stock We Don't?
Mar 2 Poster on Celsion Corporation’s Phase I/II OVATION 2 Study to be Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer
Mar 1 Celsion: Still Waiting For Godot
Mar 1 The IGO (ASX:IGO) Share Price Has Gained 110%, So Why Not Pay It Some Attention?
Feb 26 Celsion Corporation to Participate in the Virtual 33ʳᵈ Annual Roth Conference
Feb 26 Is Celsion Stock a Buy Right Now? This Is What You Need to Know
Feb 25 NeoPhotonics 400G ZR Modules Support Extended Operation up to 80C Case Temperatures
Feb 25 NeoPhotonics Reports Fourth Quarter and Fiscal Year 2020 Financial Results
Feb 25 NeoPhotonics Corp. to Host Earnings Call
Feb 25 Celsion's Ovarian Cancer Immunotherapy Shows 38% Improvement In R0 Resection Rates Versus Control Arm
Feb 25 Celsion gives update on Phase I/II GEN-1 ovarian cancer study
Back to the Main CLSN Page...